Manufacturing capacity for today and tomorrow

  • Strategic collaborations with supply chain partners enable us to perform global clinical trials for all our product candidates
  • Investments in internalizing manufacturing capabilities are based on the advancement and growth of our pipeline and future commercial needs

Gene therapy manufacturing is a critical factor in the successful development and commercialization of novel genetic medicines. We have established manufacturing and global clinical distribution that support our pipeline from lab to clinic to commercialization.

Longstanding manufacturing partnerships, in-house process development and analytics capabilities, and flexible supply chain

End-to-end clinical supply chain

Established manufacturing CMC, supply chain, and global clinical distribution from early clinical development through initial commercialization

In-house CMC capabilities

At our Princeton West Innovation Campus in Hopewell, NJ, we have invested in CMC capabilities that use state-of-the art technologies for analytical and process development

Multipurpose biologic/pharmaceutical manufacturing campus enables expansion and long-term growth

Longstanding manufacturing partnerships

Partnership with gene therapy manufacturing leader, Catalent, facilitates flexible capacity access

Our qualified current Good Manufacturing Practices (cGMP) suite is operational, and clinical manufacturing has begun producing clinical supplies for our pipeline